Impact of Dietary Antigens on Multiple Sclerosis

References

• Sibley WA. Therapeutic Claims in Multiple Sclerosis. New York: Demos Publications, 1992, 202.
   Google Scholar
• Eaton SB, Konner M. Paleolithic nutrition: a consideration of its nature and current implications. N Engl J Med 1985; 312: 283–9.
   PubMed Web of Science ®Google Scholar
• Davies JM. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 1997; 75: 113–26.
   PubMed Web of Science ®Google Scholar
• Fujinami RS, Oldstone M. Amino acid homology between the encephalitogenic site of myelin basin protein and virus: mechanism for autoimmunity. Science 1985; 230: 1043–5.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705.
   PubMed Web of Science ®Google Scholar
• Talbot PJ, Paquette JS, Ciurli C et al. Myelin basic protein and human coronavirus 229E cross- reactive T-cells in multiple sclerosis. Ann Neurol 1996; 39: 233–40.
   Google Scholar
• Ostenstad B, Dybwad A, Lea T et al. Evidence for monoclonal expansion of synovial T cells bearing VO´ 2.1/Vb5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens. Immunology 1995; 86: 168–75.
   Google Scholar
• Singh VK, Yamaki K, Donoso L et al. Yeast histone H3-induced experimental autoimmune uveitis. J Immunol 1989; 142: 1512–17.
   Google Scholar
• Cavallo MG, Fava D, Monetini L et al. Cell-mediated immune response to beta casein in recent- onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 1996; 348: 926–8.
   Google Scholar
• Scott FW. Food-induced type 1 diabetes in the BB rat. Diabetes Metab Rev 1996; 12: 341–59.
   PubMed Web of Science ®Google Scholar
• Stefferl A, Schubart A, Storch M et al. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol 2000; 165: 2859–65.
   Google Scholar
• Banwell JG, Howard R, Kabir I et al. Bacterial overgrowth by indigenous microflora in the phytohemagglutinin-fed rat. Can J Microbiol 1988; 34: 1009–13.
   Google Scholar
• Pustzai A. Dietary lectins are metabolic signals for the gut and modulate immune and hormone functions. Eur J Clin Nutr 1993; 47: 691–9.
   PubMedGoogle Scholar
• Liener IE. Nutritional significance of lectins in the diet. In: Liener IE, Goldstein IJ (eds). The Lectins; Properties, Functions and Applications in Biology and Medicine. Orlando: Academic Press, 1986, 527–52.
   Google Scholar
• Kurtzke JF. MS epidemiology worldwide. One view of current status. Acta Neurol Scand (Suppl.) 1995; 161: 23–33.
   PubMedGoogle Scholar
• Dyment DA, Sadnovich AD, Ebers GA. Genetics of multiple sclerosis. Hum Mol Genet 1997; 6: 1693–8.
   PubMed Web of Science ®Google Scholar
• Hauser SL, Fleischnick E, Weiner H et al. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology 1989; 39: 275–7.
   Google Scholar
• Allen M, Sandberg-Wollheim M, Sjogren K et al. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994; 39: 41–8.
   Google Scholar
• Ebers G, Kukay K, Bulman D et al. A full genome search in multiple sclerosis. Nat Genet 1996; 13: 469–71.
   Google Scholar
• Haines J, Pericak-Vance M, Sebonn E et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996; 13: 477–80.
   Google Scholar
• Sadovnick AD, Ebers G. Epidemiology of multiple sclerosis: a critical overview. Can J Neur Sci 1993; 20: 17–29.
   PubMed Web of Science ®Google Scholar
• Pryse-Phillips WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960–1984. Ann Neurol 1986; 20: 323–8.
   PubMedGoogle Scholar
• Svenson LW, Woodhead SE, Platt GH. Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada. Neuroepidemiology 1994; 13: 8–13.
   PubMedGoogle Scholar
• Agranoff BW. Diet and the geographical distribution of multiple sclerosis. Lancet 1994; 1974: 1061–6.
   Google Scholar
• Malosse D, Perron H, Seigneurin JM. Correlation between milk and dairy product consumption and multiple sclerosis prevalence, a worldwide study. Neuroepidemiology 1992; 11: 304–12.
   PubMed Web of Science ®Google Scholar
• Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995; 142: 733–7.
   PubMed Web of Science ®Google Scholar
• Shatin R. Multiple sclerosis and geography. Neurology 1964; 338–44.
   Google Scholar
• Hughes DA, Pinder AC, Piper Z et al. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 1996; 63: 267–72.
   Google Scholar
• Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. Part 1: Sunlight, dietary factors and epidemiology. Int J Environ Stud 1974; 6: 19–27.
   Google Scholar
• Van Noort JM, Amor S. Cell biology of autoimmune diseases. Int Rev Cytol 1998; 178: 127–206.
   PubMedGoogle Scholar
• Stinissen P, Rans J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 1997; 17: 33–75.
   PubMed Web of Science ®Google Scholar
• Rand KH, Houck H, Denslow ND et al. Molecular approach to find target(s) for oligoconal bands in multiple sclerosis. J Neurol Neurosurg Psychiatr 1977; 65: 48–55.
   Google Scholar
• Yacyshyn B, Meddings J, Sadowski D, Bowen-Yacyshyn MB. Multiple sclerosis patients have peripheral blood CD45ROzB cells and increased intestinal permeability. Dig Dis Sci 1996; 41(12): 2493–8.
   PubMedGoogle Scholar
• Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992; 23: 217–44.
   PubMedGoogle Scholar
• Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996; 17: 466–70.
   PubMedGoogle Scholar
• Baum H, Davies H, Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 1996; 17: 64–9.
   PubMedGoogle Scholar
• Pusztai A, Ewen SWB, Grant G et al. Antinutritive effects of wheat-germ agglutinin and other N-acetlyglucosamine-specific lectins. Br J Nutr 1993; 70: 313–21.
   Google Scholar
• Pusztai A, Greer F, Grant G. Specific uptake of dietary lectins into the systemic circulation of rats. Biochem Soc Trans 1989; 17: 527–8.
   Google Scholar
• Kawakami K, Yakamoto Y, Onoue K. Effect of wheat germ agglutinin on T lymphocyte activation. Microbiol Immunol 1988; 32: 413–22.
   PubMed Web of Science ®Google Scholar
• Koch AE, Shah MR, Harlow LA et al. Soluble intercellular adhesion molecule-1 in arthritis. Clin Immunol Immunopathol 1994; 71: 208–15.
   PubMedGoogle Scholar
• Shingu M, Hashimoto M, Nobunaga M et al. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis. Inflammation 1994; 18: 23–34.
   Google Scholar
• Odeh M. New insights into the pathogenesis and treatment of rheumatoid arthritis. Clin Immunol Immunopathol 1997; 83: 103–16.
   PubMedGoogle Scholar
• van den Bourne BE, Kijkmans BA, de Rooij HH et al. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol 1997; 24: 55–60.
   Google Scholar
• Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144: 33347–53.
   Google Scholar
• Perez-Maceda B, Lopez-Bote JP, Langa C, Bernabeu C. Antibodies to dietary antigens in rheumatoid arthritis—possible molecular mimicry mechanism. Clin Chim Acta 1991; 203: 153–65.
   PubMed Web of Science ®Google Scholar
• Hayes CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997; 216: 21–7.
   PubMed Web of Science ®Google Scholar
• Cordain L. Cereal grains: humanity’s double-edged sword. World Rev Nutr Dietetics 1999; 84: 19–73.
   PubMedGoogle Scholar
• Vieth R. Vitamin D supplementation, 25-hyroxyvitamin D concentrations and safety. Am J Clin Nutr 1999; 69: 842–56.
   PubMed Web of Science ®Google Scholar
• Nieves J, Cosman F, Herbert J et al. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994; 44: 1687–92.
   Google Scholar
• Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48: 271–2.
   PubMed Web of Science ®Google Scholar
• Auer DP, Schumann EM, Kumpfel T et al. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 47: 276–7.
   Google Scholar
• Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 7861–4.
   PubMed Web of Science ®Google Scholar
• VanAmerongen BM, Dijkstra CD, Lips P et al. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58(8): 1095–109.
   Google Scholar
• Cantorna M, Hayes C, DeLuca H. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128: 68–72.
   PubMed Web of Science ®Google Scholar
• Lemire J, Ince A, Takashima M. 1,25-dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992; 12: 143–8.
   PubMed Web of Science ®Google Scholar
• Mathieu C, van Etten E, Decallonne B et al. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 2004; 89–90:449–52.
   Google Scholar
• Spach KM, Pedersen LB, Nashold FE et al. Gene expression analysis suggests that 1,25- dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol Genom 2004; 18: 141–51.
   PubMed Web of Science ®Google Scholar
• Colston K, Colston MJ, Feldman D. 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 1981; 108: 1083–6.
   PubMed Web of Science ®Google Scholar
• Veenstra TD, Fahnstock M, Kumar R. An AP-1 site in the nerve growth factor expression in osteoblasts. Biochemistry 1998; 37: 5988–94.
   PubMedGoogle Scholar
• Muller K, Bendtzen K. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Different effects on CD45RAz and CD45ROz cells. Autoimmunity 1992; 14: 37–43.
   Google Scholar
• Garcion E et al. 1,25-dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 1997; 45: 255–67.
   Google Scholar
• Nataf S et al. 1,25-dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J Neur Exp Neurol 1996; 55: 904–14.
   Google Scholar
• Yang S, Smith C, DeLuca H. 1 alpha, 25-dihydroxyvitamin D3 and 19-nor-1 alpha, 25- dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo. Biochem Biophys Acta 1993; 1158: 279–86.
   PubMedGoogle Scholar
• Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004; 229: 1136–42.
   PubMed Web of Science ®Google Scholar
• van Halteren AG, Tysma OM, van Etten E et al. 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 2004; 23(3): 233–9.
   Google Scholar
• Harbige LS. Nutrition and immunity with emphasis on infection and autoimmune disease. Nutr Health 1996; 10: 285–312.
   PubMedGoogle Scholar
• Fernandes G, Jolly CA. Nutrition and autoimmune disease. Nutr Rev 1998; 56: 5162–9.
   Google Scholar
• Calder PC. Dietary fatty acids and the immune system. Nutr Rev 1998; 56: 5170–83.
   Google Scholar
• Eaton SB, Eaton SB III, Sinclair AJ et al. Dietary intake of long-chain polyunsaturated fatty acids during the Paleolithic. World Rev Nutr Dietetics 1998; 83: 12–23.
   PubMedGoogle Scholar
• Miles EA, Calder PC. Modulation of immune function by dietary fatty acids. Proc Nutr Soc 1998; 57: 277–92.
   PubMed Web of Science ®Google Scholar